Back to Search
MOHAMED MITWALLY, MD, HCLD, FACOG
MD, HCLD, FACOG
Reproductive Endocrinology Physician
NPI: 1790855716IndividualAccepts Medicare
Specialties, Licenses & Credentials
Reproductive Endocrinology PhysicianPrimary
Obstetrics & Gynecology — Reproductive Endocrinology
Code: 207VE0102X
P0765(TX)
Education
OTHER
Class of 1990
Research & Publications (20)
Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
PMID 19362305·Fertil Steril·2010
8-other
Bazedoxifene: a selective estrogen-receptor modulator.
PMID 19072496·Womens Health (Lond)·2008
6-review
Management of reproductive needs in cancer patients: clinical perspectives.
PMID 18925851·Expert Rev Anticancer Ther·2008
6-review
Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist.
PMID 17678904·Fertil Steril·2008
8-other
Fertility preservation and minimizing reproductive damage in cancer survivors.
PMID 17627459·Expert Rev Anticancer Ther·2007
6-review
Effect of cancer and cancer treatment on human reproduction.
PMID 17555391·Expert Rev Anticancer Ther·2007
6-review
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles.
PMID 17418834·Fertil Steril·2007
4-observational
Potential of aromatase inhibitors for ovulation and superovulation induction in infertile women.
PMID 17137400·Drugs·2006
6-review
Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer.
PMID 16814289·Fertil Steril·2006
8-other
Review: aromatase inhibitors for ovulation induction.
PMID 16384846·J Clin Endocrinol Metab·2006
1-meta
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.
PMID 16202169·Reprod Biol Endocrinol·2005
6-review
Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET.
PMID 15844730·J Assist Reprod Genet·2005
4-observational
Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation.
PMID 15695975·Am J Obstet Gynecol·2005
8-other
Single-dose administration of an aromatase inhibitor for ovarian stimulation.
PMID 15652918·Fertil Steril·2005
3-trial
Oestrogen-selective modulation of FSH and LH secretion by pituitary gland.
PMID 15583687·Br J Cancer·2005
8-other
Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
PMID 15350255·J Soc Gynecol Investig·2004
3-trial
Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.
PMID 15239837·Reprod Biol Endocrinol·2004
8-other
Potential cofounders in the laparoscopic detection of endometriosis.
PMID 15193516·Fertil Steril·2004
8-other
Laparoscopic management of tubal ectopic pregnancy in obese women.
PMID 14711567·Fertil Steril·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2500 METROHEALTH DR
CLEVELAND, OH 44109 - Phone
- (216) 778-7800
Quick Facts
- NPI
- 1790855716
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile